Bezos Expeditions — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Synchronsynchron.comin 𝕏Nov 2022

Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.

BiotechDeep TechMedical DevicesCampbell, US

Thomas James Oxley(Executive Officer, Director)Martin Dieck(Director)Nicholas Opie(Director)Rahul Sharma(Director)

BoardAlex Morgan(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.